Polycystic ovarian syndrome often presents alongside the metabolic syndrome: obesity, impaired glucose tolerance and type 2 diabetes, hyperlipidemia, chronic low-grade inflammation, and early-stage atherosclerosis. We have recently demonstrated that mice with impaired insulin and leptin signaling in POMC neurons exhibit a PCOS-like phenotype including systemic insulin resistance, elevated serum testosterone levels and ovarian abnormalities resulting in reduced fertility. In a separate study, we have recently shown that an HDL analog reduces cardiovascular risk factors independent of body weight, improves insulin sensitivity, reduces testosterone levels and increases estradiol levels in obese leptin-deficient female mice. We hypothesize that inflammation, insulin resistance, and elevated triglyceride levels contribute to the impairment of reproductive functioning in ob/ob and POMC-cre,LepRfloxIRflox mice. To test our hypothesis, we have administered L4-F, gemfibrozil, flutamide, metformin, and pioglitazone to separate cohorts to examine the ability of these drugs to improve fertility. Our results demonstrate that increased insulin sensitivity improves ovarian functioning in these mice and provide some insight into mechanisms involved. Thus, these mouse models offer a novel approach for examining the etiology and treatment of obesity-associated infertility. Research supported by NICHD HD056491 to JWH. (poster)